Who are Povidone-Iodine Topical Ointment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): CHG 2% w/v and IPA 70% v/v, Betadine ophthalmic prep solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/povidone-iodine-topical-ointment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Povidone-Iodine Topical Ointment — Competitive Intelligence Brief

Povidone-Iodine Topical Ointment (Povidone-Iodine Topical Ointment) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic/antimicrobial. Area: Dermatology / Infection Prevention.

marketed Topical antiseptic/antimicrobial Microbial proteins and nucleic acids (non-specific oxidative mechanism) Dermatology / Infection Prevention Small molecule Live · refreshed every 30 min

Target snapshot

Povidone-Iodine Topical Ointment (Povidone-Iodine Topical Ointment) — Marin L. Schweizer, PhD. Povidone-iodine releases iodine that directly kills microorganisms by oxidizing their cellular components and disrupting protein synthesis.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Povidone-Iodine Topical Ointment TARGET	Povidone-Iodine Topical Ointment	Marin L. Schweizer, PhD	marketed	Topical antiseptic/antimicrobial	Microbial proteins and nucleic acids (non-specific oxidative mechanism)
CHG 2% w/v and IPA 70% v/v	CHG 2% w/v and IPA 70% v/v	Johns Hopkins University	marketed	Topical antiseptic/antimicrobial combination
Betadine ophthalmic prep solution	Betadine ophthalmic prep solution	Altacor Ltd.	phase 3	Topical antiseptic/antimicrobial	Microbial proteins and nucleic acids (non-selective oxidative mechanism)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic/antimicrobial class)

Altacor Ltd. · 1 drug in this class
Marin L. Schweizer, PhD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Povidone-Iodine Topical Ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/povidone-iodine-topical-ointment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab